Austrian gaming equipment supplier Novomatic AG says it organised this month the group’s annual “NOVO Company Day”, for more ...

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

Rangers target Max Aarons has plenty of catching up to do should he choose to pursue a career at Ibrox - having gone two ...

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments ...

The French retail bank will buy the Portuguese lender from its majority owner Lone Star in the latest cross-border deal in European banking. Lawyers, Auditors to Cough Up Fees After Financial ...

Chime Financial's stock jumped in its stock-market debut Thursday, the latest sign the U.S. initial public offering market is awakening.

Zepbound, a direct competitor to Novo Nordisk's pioneering Wegovy, is already available on Lilly's website, albeit in lower doses. With the addition of the two highest-dose versions, all dosages ...

Novo Nordisk’s shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe’s largest by market capitalization. Steven Goldstein is based in London ...

The night kicked off with a thought-provoking fireside chat between Dawn Calleja, editor of Report on Business magazine, and ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Novo Nordisk is planning to open an artificial intelligence (AI) research facility in London, UK, as part of a drive to place the technology at the heart of its drug discovery operations.